Eris Lifesciences Q3 Results
- BSE: 540596
- NSE: ERIS
- ISIN: INE406M01024
- Sector: Biotechnology & Drugs
BSE
1,157.40
7.35 (0.64%)
7.35 (0.64%)Volume1.86 K
Updated: Wed 14 Oct, 2026 | 15:15:01
NSE
1,152.502.70 (0.23%)
2.70 (0.23%)Volume23.50 K
Updated: Wed 14 Oct, 2026 | 15:29:46
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Quarter ended Dec 25
Note: Comparison is on QoQ basis
Quarterly - Eris Lifesciences Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 25 | Sep 24 | QoQ Comp | Dec 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 613.42 | 557.14 | 7.00% | 356.50 | 9.86% |
| Depreciation/ Amortization | 70.34 | 80.48 | 1.82% | 45.72 | -13.37% |
| Operating Income | 194.03 | 184.03 | -11.45% | 129.79 | 14.74% |
| Net Income | 99.72 | 91.59 | -17.03% | 102.74 | 19.24% |
| Other Operating Expenses Total | 164.46 | 164.76 | 0.07% | 123.24 | -5.95% |
| Net Income Before Taxes | 145.35 | 129.11 | -15.82% | 115.87 | 25.13% |
| Total Revenue | 807.45 | 741.17 | 1.90% | 486.30 | 11.00% |
| Selling/ General/ Admin Expenses Total | 138.08 | 125.63 | 0.46% | 98.68 | 10.12% |
| Diluted Normalized EPS | 8.26 | 6.72 | -6.29% | 7.54 | 34.47% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.